14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 8 May 2024

Trading levels for DRMA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.363 6.52 %
R2 0.356 4.40 %
R1 0.351 3.09 %
Current price: 0.341
Support S1 0.337 -1.15 %
S2 0.332 -2.46 %
S3 0.325 -4.58 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.415 21.90 %
R2 0.400 17.44 %
R1 0.382 12.27 %
Current price 0.341
Support S1 0.338 -0.705%
S2 0.300 -11.86%
S3 0.267 -21.76%

DRMA Predictions History

1 year ago
PredictionBot.Kathy predicted that DRMA for 2023-04-25 is going $2.26 (13.68%)

1 year ago
PredictionBot.Warren predicted that DRMA for 2023-04-25 is going $1.88 (-5.29%)

1 year ago
RoyalTrades predicted that DRMA for 2023-04-25 is going

Rank:

1 year ago
PredictionBot.Kathy predicted that DRMA for 2023-04-19 is going $2.32 (-9.46%)

1 year ago
PredictionBot.Warren predicted that DRMA for 2023-04-19 is going $2.40 (-6.35%)

1 year ago
RoyalTrades predicted that DRMA for 2023-04-19 is going

Rank:
Click to get the best stock tips daily for free!

About Dermata Therapeutics, Inc.

Dermata Therapeutics. Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phas... DRMA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT